Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcifediol for Left Ventricular Function in Cardiopathic Patients
NCT03403933Phase 4
Key facts
- Status
- Completed
- Start
- Jan 2017
- Primary completion
- Sep 2017
- Countries
- 1
- Modality
- Orthosteric Ligands
- Drugs
- calcifediol
- Conditions
- vitamin D deficiency
01
Overview
Phase 4, open-label, single-arm trial of calcifediol in vitamin D deficiency, sponsored by IRCCS Ospedale Galeazzi-Sant'Ambrogio. Primary endpoint: Left Ventricular Ejection Fraction at 6 months. Started Jan 2017; status: completed.
02
Design
1 arm- Study design
- Non-randomizedOpen-labelSingle group
Cardiopathic patients in hypovitaminosis
Patients receive Calcifediol (Didrogyl) to correct hypovitaminosis D.
03
Endpoints
Primary
Left Ventricular Ejection Fraction
Beyond the preview
Go deeper on NCT03403933.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03403933.